A polymorphism (M129V) at codon 129 of the prion protein gene (PRNP) results in either a methionine residue (Met) or a valine residue (Val) and is known to determine susceptibility for the development of sporadic or acquired Creutzfeldt-Jakob disease (CJD). The distributions of M129V genotypes and alleles in various general populations have been reported and there are clear differences between Western Europeans and East Asians. We analysed the coding sequence of the PRNP gene in 100 healthy Turkish subjects to determine whether the distributions of the M129V genotypes and alleles or other PRNP gene variants in the Turkish population differ from those in other normal populations. Three known polymorphisms but no other gene variants were detected in the PRNP coding sequence of the Turkish individuals. Genotype frequencies at codon 129 were 57% Met/Met, 34% Met/Val and 9% Val/Val, with an allele frequency of 0.740 : 0.260 Met:Val. These distributions are considerably different from those reported for other normal populations residing in Western Europe and East Asia, except in Crete. The higher frequency of 129 Met-homozygotes in Turkey than in Western Europe suggests that the Turkish are at greater risk of developing CJD. European Journal of Human Genetics (2001) 9, 965 ± 968.
Introduction
Prion diseases are a group of fatal neurodegenerative diseases including Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE) in cattle. 1 They manifest themselves as sporadic, inherited or infectious (iatrogenic, acquired) disorders. 1 The main event in their pathogenesis appears to be the conversion of the prion protein (PrP), a normal cellular protein, to an abnormal isoform. 1 Insertions and point mutations in the prion protein gene (PRNP, MIM *176640), located on chromosome 20 in humans, are associated with inherited prion diseases (see database at www.mad-cow.org/prion_point_mutations.html). A common polymorphism (M129V) at codon 129 of the PRNP gene results in either a methionine residue (Met) or a valine residue (Val) and is known to determine susceptibility for the development of sporadic, 2 ± 5 iatrogenic 6 or variant 7 CJD (vCJD). vCJD is believed to be linked with exposure to the BSE agent. Homozygosity for Met at codon 129 is a high risk factor for CJD, being detected in 70 ± 75% of Caucasians with sporadic CJD 2 ± 5 and all patients with vCJD tested to date. 
Materials and methods
Genomic DNA was extracted by standard techniques from the peripheral blood leukocytes of 100 unrelated healthy Turkish subjects (50 women and 50 men selected from various regions of Turkey, mean age 30+10 years). The PRNP coding sequence was amplified by PCR as previously described 10 and the PCR products were separated on a 6% neutral polyacrylamide gel and examined for size variations before direct sequencing. 10 In case of the detection of a size variation, the normal and variant fragments were firstly eluted from the gel, then sequenced. In order to confirm the genotypes of some individuals, at codons 117, 129 and at position 721 in the intron sequence flanking the 5' end of exon 2 (721A/G 11 ), a fragment containing the three polymorphisms was amplified using forward primer 5'-GTTCACCCTTTTCTTCATTTTG-3' and reverse primer 5'-TGATGGGCCTGCTCATGGCAC-3' in standard PCR conditions, then submitted to the endonuclease restriction enzymes PvuII and TaiI. The chi-square test was used to compare genotype and allele frequencies in normal populations. All significance values are two-tailed.
Results and discussion
Variations in the PRNP gene and the potential influence of these variations onto susceptibility to CJD have never been studied in the Turkish population, which is located at the boundary between Europe and Asia. We studied 100 Turkish individuals and found three polymorphisms in the coding sequence. Two subjects (2%) were found to carry a 24 base pair (bp) deletion between repeats R3 and R4 in the octapeptide coding region. Twenty-four bp deletions in the octapeptide coding region of PRNP which spans codons 51 to 91, are rare non-pathogenic polymorphisms, and have previously been reported in North African 12 and Japanese 13 individuals as well as in Western Europeans, 14 with an allelic frequency of about 0.5% in the latter population. These deletions are probably generated by unequal crossing-over between normal alleles. Five subjects (5%) harboured a GCA (Ala)-GCG (Ala) substitution at codon 117. This substitution is a silent mutation that does not modify the coding amino acid alanine but alters a PvuII restriction site. This polymorphism is present in around 11% of Western Europeans (UnitedKingdom 11 ). However, it has never been found in East Asians including 62 Han Chinese subjects from Taõ Èwan, 9 and a small number of Japanese (n=16), Thai (n=11) and Nepalese (n=8) individuals.
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The genotype frequencies at codon 129, ATG(Met)/ GTG(Val), in the Turkish population were 57% Met/Met, 34% Met/Val and 9% Val/Val, with an allele frequency of 0.740 : 0.260 Met:Val (see Table 1 Consequently, the distributions of the M129V genotypes and alleles in the Turkish population differ considerably from those reported for other normal populations residing in either Western Europe or East Asia, with the notable exception of Cretan natives. A recent report 19 found that the high rate of PRNP 129Met homozygosity in Crete was associated with a local increase in the incidence of sporadic CJD. As homozygosity at PRNP codon 129 is a recognized risk factor for sporadic and acquired CJD in Caucasians 5, 21 and heterozygosity is protective, 2 ± 4,21 the higher frequency of 129Met-homozygotes in Turkey than in Western Europe would also suggest that the Turkish are at increased risk of developing CJD.
